Loxo Oncology (NASDAQ:LOXO) reported Q4 2017 earnings this Morning, coming in at ($0.69) per share, beating Wall Street’s estimates of ($1.14) per Share. Revenue for the quarter came in at $21.30 million missing the streets estimates Recent Insider Trading for Loxo Oncology (NASDAQ:LOXO)
- On 2/13/2018 Joshua H Bilenker, CEO, sold 15,000 with an average share price of $96.57 per share and the total transaction amounting to $1,448,550.00.
- On 2/13/2018 Naarden Jacob Van, Insider, sold 3,082 with an average share price of $96.34 per share and the total transaction amounting to $296,919.88.
- On 2/12/2018 Jennifer Burstein, VP, sold 1,700 with an average share price of $93.24 per share and the total transaction amounting to $158,508.00.
- On 1/22/2018 Avi Z Naider, Director, sold 15,000 with an average share price of $100.00 per share and the total transaction amounting to $1,500,000.00.
- On 1/17/2018 Joshua H Bilenker, CEO, sold 15,000 with an average share price of $88.21 per share and the total transaction amounting to $1,323,150.00.
- On 1/17/2018 Naarden Jacob Van, Insider, sold 3,082 with an average share price of $88.21 per share and the total transaction amounting to $271,863.22.
Recent Trading for Loxo Oncology (NASDAQ:LOXO) Shares of Loxo Oncology closed the previous trading session at 108.00 down -3.22 2.90% with shares trading hands.